{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:55:47Z","timestamp":1787504147457,"version":"build-2736575974"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"6","funder":[{"name":"Research Participation Program"},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006229","name":"Oak Ridge Institute for Science and Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006229","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Energy and the Centers for Disease Control and Prevention"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>In this study, we explored key prescription drug monitoring program-related outcomes among clinicians from a broad cohort of Massachusetts healthcare facilities following prescription drug monitoring program (PDMP) and electronic health record (EHR) data integration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Outcomes included seven-day rolling averages of opioids prescribed, morphine milligram equivalents (MMEs) prescribed, and PDMP queries. We employed a longitudinal study design to analyze PDMP data over a 15-month study period which allowed for six and a half months of pre- and post-integration observations surrounding a two-month integration period. We used longitudinal mixed effects models to examine the effect of EHR integration on each of the key outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Following EHR integration, PDMP queries increased both through the web-based portal and in total (0.037, [95% CI\u2009=\u20090.017, 0.057] and 0.056, [95% CI\u2009=\u20090.035, 0.077]). Both measures of clinician opioid prescribing declined throughout the study period; however, no significant effect following EHR integration was observed. These results were consistent when our analysis was applied to a subset consisting only of continuous PDMP users.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results support EHR integration contributing to PDMP utilization by clinicians but do not support changes in opioid prescribing behavior.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/pm\/pnae012","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:47:01Z","timestamp":1708649221000},"page":"380-386","source":"Crossref","is-referenced-by-count":2,"title":["Changes in opioid prescribing and prescription drug monitoring program utilization following electronic health record integration\u2014Massachusetts, 2018"],"prefix":"10.1093","volume":"25","author":[{"given":"Brian","family":"Corry","sequence":"first","affiliation":[{"name":"Division of Overdose Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention , Atlanta, GA 30341,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J","family":"Cremer","sequence":"additional","affiliation":[{"name":"Division of Overdose Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention , Atlanta, GA 30341,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7675-5448","authenticated-orcid":false,"given":"Christopher","family":"Donnelly","sequence":"additional","affiliation":[{"name":"Division of Overdose Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention , Atlanta, GA 30341,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Wesley M","family":"Sargent","sequence":"additional","affiliation":[{"name":"Division of Overdose Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention , Atlanta, GA 30341,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Mells","sequence":"additional","affiliation":[{"name":"Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, GA 30333,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodd","family":"Kelly","sequence":"additional","affiliation":[{"name":"Massachusetts Department of Public Health, Massachusetts Prescription Monitoring Program, Bureau of Health Professions Licensure , Boston, MA 02108,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Massachusetts Department of Public Health, Massachusetts Prescription Monitoring Program, Bureau of Health Professions Licensure , Boston, MA 02108,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard D","family":"Young","sequence":"additional","affiliation":[{"name":"Massachusetts Department of Public Health, Massachusetts Prescription Monitoring Program, Bureau of Health Professions Licensure , Boston, MA 02108,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,2,24]]},"reference":[{"issue":"457","key":"2025082211514870400_pnae012-B1","first-page":"1","article-title":"Drug overdose deaths in the United States, 2001\u20132021","author":"Spencer","year":"2022","journal-title":"NCHS Data Brief"},{"key":"2025082211514870400_pnae012-B2","author":"Centers for Disease Control and Prevention"},{"issue":"33","key":"2025082211514870400_pnae012-B3","doi-asserted-by":"crossref","first-page":"837","DOI":"10.15585\/mmwr.mm6533a2","article-title":"Fentanyl law enforcement submissions and increases in synthetic opioid-involved overdose deaths - 27 states, 2013-2014","volume":"65","author":"Gladden","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"34","key":"2025082211514870400_pnae012-B4","doi-asserted-by":"crossref","first-page":"897","DOI":"10.15585\/mmwr.mm6634a2","article-title":"Trends in deaths involving heroin and synthetic opioids excluding methadone, and law enforcement drug product reports, by census region\u2014United States, 2006-2015","volume":"66","author":"O'Donnell","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025082211514870400_pnae012-B5","author":"National Institute on Drug Abuse"},{"issue":"2","key":"2025082211514870400_pnae012-B6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/ADM.0000000000000708","article-title":"Patterns of prescription opioid use prior to self-reported heroin initiation","volume":"15","author":"Hartung","year":"2021","journal-title":"J Addict Med"},{"key":"2025082211514870400_pnae012-B7","doi-asserted-by":"crossref","first-page":"108061","DOI":"10.1016\/j.drugalcdep.2020.108061","article-title":"Opioid prescribing history prior to heroin overdose among commercially insured adults","volume":"212","author":"Lagisetty","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"2025082211514870400_pnae012-B8","author":"Centers for Disease Control and Prevention","year":"2021"},{"key":"2025082211514870400_pnae012-B9","volume-title":"Integrating & Expanding Prescription Drug Monitoring Program Data: Lessons from Nine States","author":"Centers for Disease Control and Prevention","year":"2017"},{"issue":"3","key":"2025082211514870400_pnae012-B10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain\u2014United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"2025082211514870400_pnae012-B11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/epirev\/mxaa002","article-title":"Prescription drug monitoring programs and prescription opioid-related outcomes in the United States","volume":"42","author":"Puac-Polanco","year":"2020","journal-title":"Epidemiol Rev"},{"issue":"26","key":"2025082211514870400_pnae012-B12","doi-asserted-by":"crossref","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","article-title":"Vital signs: changes in opioid prescribing in the United States, 2006\u20132015","volume":"66","author":"Guy","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025082211514870400_pnae012-B13","author":"Institute for Intergovernmental Research"},{"key":"2025082211514870400_pnae012-B14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2019.02.010","article-title":"Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing","volume":"199","author":"Strickler","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"2025082211514870400_pnae012-B15","doi-asserted-by":"crossref","first-page":"108405","DOI":"10.1016\/j.drugalcdep.2020.108405","article-title":"Changes in opioid prescribing after implementation of mandatory registration and proactive reports within California's prescription drug monitoring program","volume":"218","author":"Castillo-Carniglia","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"2025082211514870400_pnae012-B16","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/ADM.0000000000000905","article-title":"The impact of a PDMP-EHR data integration combined with clinical decision support on opioid and benzodiazepine prescribing across clinicians in a metropolitan area","volume":"16","author":"Calcaterra","year":"2022","journal-title":"J Addict Med"},{"issue":"2","key":"2025082211514870400_pnae012-B17","first-page":"64","article-title":"The use of a statewide prescription drug monitoring program by emergency department physicians","volume":"116","author":"Hernandez-Meier","year":"2017","journal-title":"WMJ"},{"issue":"4","key":"2025082211514870400_pnae012-B18","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/pm\/pnz289","article-title":"Barriers to utilization of prescription drug monitoring programs among prescribing physicians and advanced practice registered nurses at veterans health administration facilities in Oregon","volume":"21","author":"Mastarone","year":"2020","journal-title":"Pain Med"},{"issue":"3","key":"2025082211514870400_pnae012-B19","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1377\/hlthaff.2014.1085","article-title":"Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to access","volume":"34","author":"Rutkow","year":"2015","journal-title":"Health Aff (Millwood)"},{"issue":"4","key":"2025082211514870400_pnae012-B20","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/acem.12905","article-title":"Usability of the Massachusetts prescription drug monitoring program in the emergency department: a mixed-methods study","volume":"23","author":"Poon","year":"2016","journal-title":"Acad Emerg Med"},{"key":"2025082211514870400_pnae012-B21","author":"Institute for Intergovernmental Research"},{"key":"2025082211514870400_pnae012-B22","author":"Drug Enforcement Administration","year":"2020"},{"key":"2025082211514870400_pnae012-B23"},{"key":"2025082211514870400_pnae012-B24","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1093\/pm\/pnab051","article-title":"Opioid prescribing after implementation of single click access to a state prescription drug monitoring program database in a health system's electronic health record","author":"Weiner","year":"2021","journal-title":"Pain Med."},{"issue":"5","key":"2025082211514870400_pnae012-B25","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/pm\/pny095","article-title":"An experimental test of the effectiveness of unsolicited reporting by a prescription drug monitoring program in reducing inappropriate acquisition of opioids","volume":"20","author":"McDonald","year":"2019","journal-title":"Pain Med"},{"issue":"9","key":"2025082211514870400_pnae012-B26","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/pds.3666","article-title":"Prescriber response to unsolicited prescription drug monitoring program reports in Massachusetts","volume":"23","author":"Thomas","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"2025082211514870400_pnae012-B27","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/pm\/pnx044","article-title":"Unsolicited reporting to prescribers of opioid analgesics by a state prescription drug monitoring program: an observational study with matched comparison group","volume":"19","author":"Young","year":"2018","journal-title":"Pain Med"},{"issue":"6","key":"2025082211514870400_pnae012-B28","doi-asserted-by":"crossref","first-page":"e221852","DOI":"10.1001\/jamahealthforum.2022.1852","article-title":"Effect of integrating access to a prescription drug monitoring program within the electronic health record on the frequency of queries by primary care clinicians: a cluster randomized clinical trial","volume":"3","author":"Neprash","year":"2022","journal-title":"JAMA Health Forum"},{"issue":"3","key":"2025082211514870400_pnae012-B29","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/1556-4029.14665","article-title":"The fentanyl phase of the opioid epidemic in Cuyahoga County, Ohio, United States","volume":"66","author":"Deo","year":"2021","journal-title":"J Forensic Sci"},{"issue":"3","key":"2025082211514870400_pnae012-B30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s13181-021-00837-4","article-title":"Impact of a mandatory prescription drug monitoring program check on emergency department opioid prescribing rates","volume":"17","author":"Watson","year":"2021","journal-title":"J Med Toxicol"}],"container-title":["Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/painmedicine\/article-pdf\/25\/6\/380\/58040013\/pnae012.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/painmedicine\/advance-article-pdf\/doi\/10.1093\/pm\/pnae012\/57104434\/pnae012.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/painmedicine\/article-pdf\/25\/6\/380\/58040013\/pnae012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T15:51:54Z","timestamp":1755877914000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/painmedicine\/article\/25\/6\/380\/7614098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,24]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,2,24]]},"published-print":{"date-parts":[[2024,5,3]]}},"URL":"https:\/\/doi.org\/10.1093\/pm\/pnae012","relation":{},"ISSN":["1526-2375","1526-4637"],"issn-type":[{"value":"1526-2375","type":"print"},{"value":"1526-4637","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,6,1]]},"published":{"date-parts":[[2024,2,24]]}}}